Related Experiment Video
Updated: Mar 24, 2026
07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
10.4K
The next step in translational research: lessons learned from the first preclinical randomized controlled trial
Gemma Llovera1,2, Arthur Liesz3,4
1Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
Journal of Neurochemistry
|March 13, 2016
Summary
Preclinical randomized controlled trials (pRCTs) can bridge the gap between experimental and clinical research. Lessons learned from the first pRCT offer insights to improve future studies and enhance translational research reproducibility.
Area of Science:
- Biomedical Research
- Translational Science
Background:
- Low reproducibility in preclinical trials and poor translation to clinical settings impede biomedical progress.
- Standardized guidelines and multicenter preclinical randomized controlled trials (pRCTs) are proposed solutions to overcome translational roadblocks.
Purpose of the Study:
- To review experiences and lessons learned from the first multicenter pRCT.
- To provide suggestions for optimizing future pRCTs and improving translational research outcomes.
Main Methods:
- The study involved the first multicenter preclinical randomized controlled trial (pRCT) adopting clinical study design elements.
- Standardized protocols and a coordinated approach were used with independent multinational research centers.
Main Results:
- The feasibility of a coordinated approach with standardized protocols in multinational centers was confirmed.
- Difficulties were encountered in protocol adherence and data analysis during the pRCT.
Conclusions:
- The first pRCT demonstrated the potential of this approach but highlighted challenges in execution.
- Addressing identified obstacles is crucial for enhancing the performance and success of future pRCTs in translational research.
More Related Videos
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
01:28Preclinical Development: Overview
6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
01:16Clinical Trials
11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.1K
01:11Clinical Trials: Overview
5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
380
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
380
01:16Crossover Experiments
4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K